Tags : Discovery

Pharma

Genentech Signs an Exclusive License Agreement with X-Chem to Discover

Shots: X-Chem to receive an up front and is eligible to receive research, development and regulatory milestone along with royalties on sales of therapies resulting from the collaboration Genentech will lead further development and commercialization of any potential new therapies and retain exclusive rights to compounds derived from the collaboration. Additionally, Genentech get an exclusive […]Read More

Pharma

Evotec Collaborates with Rappta Therapeutics to Focus on Oncology Target

Shots: Evotec to receive research funding & is eligible for milestones. Evotec will support Rappta’s program of developing small molecule activators of the enzyme PP2A The collaboration leverages Evotec’s integrated platform for drug discovery and development and its oncology expertise coupled with state-of-the-art technologies PP2A is a serine/threonine phosphatase that functions as a tumor suppressor […]Read More

Biotech COVID-19

AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2

Shots: AstraZeneca highlighted its efforts towards the development of Ab against the pandemic SARS-CoV-2 virus by deploying its internal expertise and via news collaboration with government and academia The Chinese Academy of Sciences and Vanderbilt University Medical Center are providing AstraZeneca with genetic sequences for Ab, discovered against SARS2-CoV-2 for further in silico and in […]Read More

Pharma

Roche Signs a License Agreement with Arrakis Therapeutics for the

Shots: Arrakis to receive $190M up front in cash and is eligible to get several billion dollars in pre/clinical and commercial milestones along with royalties for products emerging from the collaboration Arrakis will be responsible for discovery and research activities of each target to a defined point while Roche will get right to exclusively pursue […]Read More

Biotech COVID-19

Iktos and SRI Collaborate to Accelerate Discovery and Development of

Shots: The collaboration will combine Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to develop optimized compound & to facilitate the identification of drug therapies treating multiple viruses, including influenza and COVID-19 Iktos’AI technology is based on deep generative models that speed up the drug discovery process by automatically designing virtual novel […]Read More

Biotech COVID-19

Janssen Expands its Collaboration with BARDA to Expedite the Discovery

Shots: The public-private collaboration will expand Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules, with the goal to identify compounds with antiviral activity against SARS-CoV-2 As per the collaboration, partners will share the research and development costs and mobilize resources to screen a library of antiviral molecules for activity […]Read More

Pharma

C4X Discovery Signs a Neurodegeneration Drug Discovery Agreement with PhoreMost

Shots: The agreement collaborates C4XD’s Taxonomy3 (target identification platform) with PhoreMost’s SITESEEKER (screening platform) to accelerate drug discovery initially focusing on Parkinson’s disease with expected profit sharing by both the companies on validated targets The focus of the agreement is to advance C4XD drug discovery pipeline by validating targets identified by C4XD’s Taxonomy3 with the […]Read More